Skip to main content
. 2012 Jul 27;41(4):1204–1212. doi: 10.3892/ijo.2012.1576

Table II.

Akt isoforms expression and compartmentalization in a group of patients with HER2-positive metastatic breast cancer.

Akt isoform IHC staining No. of patients %
Akt1 Negative 17 23.0
Weak 46 62.1
Strong 9 12.2
NA 2 2.7
Akt2 Negative 0
Weak 45 60.8
Strong 26 35.1
NA 3 4.1
pAkt Thr308 Negative 10 13.5
Cytoplasmic only 22 29.7
Nuclear and cytoplasmic 38 51.4
NA 4 5.4
pAkt Ser473 Negative 5 6.8
Cytoplasmic only 16 21.6
Nuclear and cytoplasmic 49 66.2
NA 4 5.4

NA, not assessed; no., number.